Loading...

AML (ACUTE MYELOID LEUKEMIA) TRANSLOCATION PANEL BY RT PCR, EDTA BLOOD

image not found

NABL Cap Accredited 
The AML Translocation Panel by RT-PCR is a specialized molecular test that detects key chromosomal translocations associated with acute myeloid leukemia. Using EDTA blood, Metropolis Healthcare performs sensitive real-time PCR analysis to identify genetic changes that guide diagnosis, prognosis, and personalized treatment planning. This panel is particularly useful for patients with suspected AML, abnormal blood counts, or those requiring precise molecular characterization for therapy decisions.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 7,950.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:L0118

Frequently Asked Questions (FAQ's):

What does the AML Translocation Panel include?
It detects common chromosomal translocations in acute myeloid leukemia that influence treatment and prognosis.

Who should take this test?
Patients with suspected AML, abnormal hematologic findings, or those needing molecular confirmation of leukemia.

How is the sample collected?
A blood sample is collected in an EDTA tube for RT-PCR analysis.

Can this test confirm AML diagnosis?
Yes, identification of specific translocations supports definitive diagnosis and risk stratification.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses real-time PCR to ensure sensitive, accurate detection of AML-associated genetic changes.

Is fasting required for this test?
No fasting is required.

Can this test guide treatment decisions?
Yes, detecting translocations helps clinicians choose targeted therapies and plan personalized treatment.

How long does it take to receive results from Metropolis Healthcare?
Results are typically available within the standard molecular testing turnaround time.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab